非洲楝树皮粉与山椒树皮粉组合在小鼠中显示抗疟活性
研究评估了非洲楝(Enantia chlorantha)与山椒(Uvaria chamae)茎皮粉单用及组合对氯喹敏感和耐药伯氏疟原虫感染小鼠的抗疟活性,并观察与青蒿琥酯-阿莫地喹(ACT)和氯喹的相互作用。结果显示单用粉末在200 mg/kg时具显著化学抑制和治愈活性,组合粉末在25 mg/kg时化学抑制活性显著,与氯喹或ACT联用呈现相加作用。
要点
- 单用非洲楝粉200 mg/kg化学抑制86%、治愈77%;山椒粉分别为83%和76%。
- EU3组合(2:1)25 mg/kg化学抑制活性85.23%。
- EU3与氯喹或ACT联用呈相加作用,化学抑制77.61%~75.87%,治愈93.01%~96.66%。
核心结论
- 非洲楝与山椒茎皮粉组合可增强抗疟活性,与氯喹或ACT联用呈相加作用。
研究设计与样本
- 小鼠体内实验,采用氯喹敏感伯氏疟原虫NK65和氯喹耐药伯氏疟原虫ANKA感染模型。
- 单用粉末灌胃剂量6.25~200 mg/kg,组合粉末剂量6.25~25 mg/kg。
- 组合比例包括1:1(EU1)、1:2(EU2)和2:1(EU3),以50%丙二醇助悬。
- 评估化学抑制模型和治愈模型,并观察与青蒿琥酯-阿莫地喹(ACT)和氯喹联用效果。
- 对组合粉末的正己烷提取物进行GC-MS分析。
主要发现
- 200 mg/kg单用非洲楝粉化学抑制86%、治愈77%;山椒粉分别为83%和76%。
- 25 mg/kg EU3化学抑制活性85.23%。
- 6.25 mg/kg EU3+氯喹化学抑制77.61%、治愈93.01%;EU3+ACT化学抑制75.87%、治愈96.66%。
- GC-MS指纹显示组合粉末主要含倍半萜类、含氧倍半萜类、脂肪酸酯和植物甾醇。
关键数值与推荐
- 单用粉末200 mg/kg时化学抑制活性86%(非洲楝)和83%(山椒),治愈活性77%(非洲楝)和76%(山椒)。
- EU3(2:1)25 mg/kg化学抑制活性85.23%。
- 6.25 mg/kg EU3+氯喹化学抑制77.61%、治愈93.01%;EU3+ACT化学抑制75.87%、治愈96.66%。
临床怎么用
- 提示非洲楝与山椒茎皮粉组合可能作为抗疟候选,与氯喹或ACT联用可能增效,但尚需临床验证。
局限性
- 研究仅在小鼠中进行,未报告人体数据。
- 未报告毒性、药代动力学及活性成分的具体定量信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The stem bark of Enantia chlorantha Oliver (Annonaceae) and Uvaria chamae P. Beauv (Annonaceae) is widely used in African ethnomedicine for the treatment of malaria. AIM OF THE STUDY: This study investigated the antimalarial activities of E. chlorantha and U. chamae stem bark powders in order to optimize their antimalarial activity. It also aimed to assess possible herb-drug interaction with orthodox antimalarial drugs. MATERIALS AND METHODS: The single and combined [1:1 (EU1); 1:2 (EU2) and 2:1 (EU3)] powders of E. chlorantha and U. chamae were reconstituted by suspending in propylene glycol (50%). Evaluation of the chemosuppressive and curative antimalarial models was carried out by oral administration of the single (6.25-200 mg/kg) and combined (6.25-25 mg/kg) powders on mice infected with the chloroquine-sensitive Plasmodium berghei NK65 and chloroquine-resistant Plasmodium berghei ANKA, respectively. Co-administration with artesunate-amodiaquine (ACT) and chloroquine was also assessed. The n-hexane extracts of the combined powders were analyzed individually by GC-MS. RESULTS: At 200 mg/kg, E. chlorantha and U. chamae powders each gave significant chemosuppressive (86% and 83%) and curative (77% and 76%) activities, respectively. At 25 mg/kg, EU3 exhibited significant chemosuppressive activity (85.23%). At 6.25 mg/kg, EU3+CQ and EU3+ACT had chemosuppressive (77.61% and 75.87%) and curative (93.01% and 96.66%) activities, respectively. The GC-MS fingerprint of the combined powders revealed predominantly sesquiterpenes, oxygenated sesquiterpenes, fatty acid esters, and phytosterols. CONCLUSION: Antimalarial activity was enhanced with combination of the powders while additive interaction was observed with the herb-drug combinations.
引用
- Olawuni OF, Adepiti AO, Babamuyiwa BO, et al. Combinations of stem bark powders of Enantia chlorantha and Uvaria chamae showed antimalarial activities in mice. J Ethnopharmacol. 2026. PMID: 42349770. doi:10.1016/j.jep.2026.122032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。